Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients
A prospective study in Gut Journal quantifies the cancer risk associated with each gastritis stage.
Prognostic significance of the preoperative ratio of C-reactive protein to albumin and neutrophil–lymphocyte ratio in gastric cancer patients
A recent study in the World Journal of Surgery found a combination of CRP/Alb ratio and NLR can be an independent prognostic... Read More
Genetic analysis clarifies stomach cancer risk factors
Do you know risk factors for gastric cancer? Using genomic technologies, a study published in Cancer Cell looks into the effects of... Read More
Single Blood Test Screens for Eight Cancer Type
Although it’s a long way from being a marketable device, researchers at Johns Hopkins Medicine Kimmel Cancer Center have developed a blood... Read More
HIPEC Increased Survival in Gastric Cancer With Peritoneal Metastasis
Data shared at ASCO’s Gastrointestinal Cancers Symposium also included research that found hyperthermic intraperitoneal chemotherapy (HIPEC), which delivers chemotherapy directly to cancer... Read More
Minimally Invasive Surgery for Gastric Cancer: Is There a Benefit to Our Patients?
Earlier detection for gastric cancer is becoming possible and attention is finally on our younger patients, whose incidence is increased. Read more... Read More
Efforts Continue to Optimize Immunotherapy in Gastric Cancer
Want an immunotherapy refresher? Check out this recent presentation on immunotherapy in gastric cancer in OncLive.
Daiichi Sankyo Presents Updated Data for DS-8201 in Patients with HER2-Expressing Gastric Cancer at ASCO 2018 Gastrointestinal Cancers Symposium
Encouraging phase 1 results were shared at ASCO for DS-8201 (an antibody drug conjugate) treatment for HER2-positive gastric cancer.
Biomarkers may help predict outcomes in gastric cancer patients who abuse alcohol
A recent study in The American Journal of Pathology on alcohol abuse and gastric cancer finds biomarkers may help predict patient outcomes... Read More
Phase 1b/2 Study of Margetuximab in Combination with Pembrolizumab Presented at 2018 ASCO Gastrointestinal Cancers Symposium
At ASCO this weekend, new data was shared from a clinical trial of margetuximab and pembrolizumab for patients with advanced gastric cancer,... Read More
